BIOMAT Database Logo BIOMAT Database Logo

[Changes in blood sugar, IRI, growth hormone and plasma glucagon induced by somatostatin in subjects with liver cirrhosis]. 1977

G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu
Effect of somatostatin on blood sugar, plasma growth hormone, and glucagon levels in diabetic children.
July 1976, Diabetes,
G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu
Growth hormone in blood plasma of patients with liver cirrhosis.
January 1978, Acta medica Polona,
G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu
[Changes in plasma insulin and growth hormone after intravenous glucagon in hepatic cirrhosis].
October 1976, Minerva medica,
G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu
Effects of synthetic somatostatin on endotoxin-induced changes of growth hormone, cortisol and insulin in plasma, blood sugar and blood leukocytes in man.
June 1975, Klinische Wochenschrift,
G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu
[Changes in blood sugar, and insulin levels induced by somatostatin in normal, diabetic and acromegalic subjects].
April 1976, Minerva medica,
G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu
[The blood sugar raising effect of glucagon in liver cirrhosis].
August 1982, Orvosi hetilap,
G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu
[Changes in blood glucose, insulin, cortisol, growth hormone and glucagon induced by sulfonylures].
January 1982, Die Medizinische Welt,
G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu
Thyrotrophin-releasing hormone-induced growth hormone secretion in ducks: independence of peripheral plasma somatostatin, insulin, and glucagon.
June 1988, General and comparative endocrinology,
G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu
[Changes in thyroid hormone metabolism in subjects with liver cirrhosis].
March 1983, Minerva medica,
G Gragnoli, and I Tanganelli, and G Martinelli, and A R Genazzani, and L Brandi, and A Kristodhullu
The early rise of plasma growth hormone (HGH) and immunoreactive insulin (IRI) in children following intravenous glucagon.
February 1972, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!